Lake Street Maintains Hold on AVITA Medical, Raises Price Target to $3.5
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Frank Takkinen maintains AVITA Medical (NASDAQ:RCEL) with a Hold and raises the price target from $3 to $3.5.
Lake Street analyst Frank Takkinen maintains AVITA Medical (NASDAQ:RCEL) with a Hold and raises the price target from $3 to $3.5.